Cargando…
Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial
OBJECTIVE: Data on osteoarthritis patients from the PRECISION trial were used to evaluate the cost-effectiveness of celecoxib (100 mg twice daily) versus ibuprofen (600–800 mg three times daily) and naproxen (375–500 mg twice daily). The perspective was that of the United Arab Emirates (UAE) healthc...
Autores principales: | Chirikov, Viktor V, Walker, Chris, Stephens, Jennifer M, Schepman, Patricia, Chambers, Richard, Bakir, Mahmoud, Poorman, Gregory W, Haider, Seema, Farghaly, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141397/ https://www.ncbi.nlm.nih.gov/pubmed/34040400 http://dx.doi.org/10.2147/CEOR.S280556 |
Ejemplares similares
-
Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis
por: Essex, Margaret Noyes, et al.
Publicado: (2014) -
Recent Advances in the Synthesis of Ibuprofen and Naproxen
por: Ha, Min-Woo, et al.
Publicado: (2021) -
Syntheses and cytotoxicity of phosphatidylcholines containing ibuprofen or naproxen moieties
por: Kłobucki, Marek, et al.
Publicado: (2019) -
Cartilage targeted chemical delivery of naproxen and ibuprofen for the treatment of arthritis
por: Pawar, Vijay, et al.
Publicado: (2012) -
The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
por: Breitner, John C. S, et al.
Publicado: (2006)